Research Group >
New data presented at the American Thoracic Society Conference showed nintedanib slows loss of pulmonary function in people living with systemic sclerosis associated ILD >
+ d'info
Scleroderma Association of B.C. research
Researcher Profiles
- Dr. James V. Dunne – Biography
- Dr. Kevin J. Keen – Biography
- Dr. Chris Ryerson – Biography
- Dr. Pearce Wilcox – Biography
Current research project summaries
Canadian Scleroderma Research Group
Researcher Profiles
- Dr. Ariel Masetto – Biography
- Dr. Deborah Assayag – Biography
- Dr. Marie Hudson Biography
- Dr. Celia M.T. Greenwood Biography
- Dr. Murray Baron Biography
- Dr. David Langleben Biography
- Dr. Russell J. Steele Biography
Current research project summaries
The Scleroderma Patient-centered Intervention Network (SPIN)
Other Research Groups
Research funding
Patient Participation in Research
Criteria and standards for awarding
Researcher Profiles
Current research project summaries
New data presented at the American Thoracic Society Conference showed nintedanib slows loss of pulmonary function in people living with systemic sclerosis associated ILD
To read the press release, click here.
British
Columbia
Columbia
Manitoba
See the
testimonial
testimonial
« Ever since I was diagnosed with scleroderma, I became aware of how precious life was; it is as if I felt a sudden urgency to live life to its fullest. »